Angelman Syndrome Foundation opener
  • Angelman Strong
  • Contact Registry
  • News
  • Blog
DOnate
  • What is Angelman Syndrome
    • Symptoms and Causes
    • Testing and Diagnosis
    • Genetics of AS
    • Photo Gallery
  • For Parents
    • Newly Diagnosed
    • Accomplishments of Individuals
    • Participate in Research Studies
    • Angelman Therapeutics
  • Research
    • ASF Funded Research
    • Call for Proposals
    • Clinical Trials
    • Research Studies
    • LADDER
    • Research Funding Philosophy
  • Make an Impact
    • ASF Cure Club
    • Ways To Donate
    • Fundraise
    • Committees & Groups
    • Send Encouragement
    • Shop & Support ASF
    • Volunteer Opportunities
  • Clinics
    • Find a Clinic
    • Clinic Patient Survey
    • For Clinicians
    • Jacob Pritzker Fellowship Program
    • FAQs
  • Resources
    • Search by Topic
    • Adult Resources
    • ASF Family Resource Team
    • ASF Family Fund
    • ASF Family Champions
    • Angelman Syndrome A to Z
    • ASF Podcast
    • Behavior Resources
    • Communication Resources
    • Counseling Services
    • Educational Webinars
    • Federal Resources
    • IEP Resources
    • International AS Resources
    • Medical Resources
    • Seizures
    • Sibling Programs
    • State Resources
  • Events
  • About
    • Contact ASF
    • Contact Registry
    • Our Partners
    • Board of Directors
    • Communication Advisory Committee
    • Financial Transparency
    • History of ASF and Angelman Syndrome
    • Medical Advisory Board
    • Parent Advisory Committee
    • Scientific Advisory Committee
    • Receive Texts & Emails
    • Privacy
Dr. Ron Thibert

articles and announcements

Categories: Clinical Trial

Dr. Ron Thibert
January 23, 2020

Low Glycemic Index Therapy (LGIT) for the Treatment of Epilepsy in Angelman Syndrome

$28,850 ASF has supported varied initiatives to improve treatment of seizures in AS and this grant aimed at exploring alternatives to the use of the very restrictive ketogenic diet. In the low glycemic diet, the extremely high lipid content of […]

Read more
December 22, 2019

Levodopa/carbidopa treatment of children with Angelman Syndrome

$72,855 ASF has previously supported work at understanding if levodopa might have a potential therapeutic role in AS. This grant provides partial support to a larger clinical trial study which is aimed at implementing a controlled trial of levodopa supplementation […]

Read more

Recent Posts

  • MavriX Bio Announces New Potential Gene Therapy for Angelman Syndrome
  • Oak Hill Bio Obtain Global Rights for Rugonersen
  • Community Advisory Board
  • First Patient(s) Dosed in Ultragenyx Phase 3 Aspire Study
  • Ionis Releases News about Clinical Trial of ION582

Browse

  • What is Angelman Syndrome
  • For Parents
  • ASF Funded Research
  • Make an Impact
  • Events
  • About
  • Angelman Resources & Education
  • Contact Registry
  • News
Address Angelman Syndrome Foundation
3015 E. New York Street
Suite A2-#285
Aurora, IL 60504
Phone800.432.6435 Emailinfo@angelman.org

Connect

  • facebook
  • twitter
  • linkedin
  • instagram
  • pinterest
  • rss
  • youtube

The Mission

The mission of the Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.

  • 4-star charity navigator logo
  • Combined Federal Campaign logo
  • Community Congress logo
Copyright © 2025 Angelman Syndrome Foundation. ALL Rights Reserved. | Site design: BRAND INSPIRATION, LLC